发明名称 |
PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY |
摘要 |
The invention relates to treatment and/or prevention of nerve injury. In one embodiment, the present invention provides a method of preserving the neuromuscular junction (NMJ) in an individual by administering a therapeutically effective dosage of a composition comprising an inhibitor of Wnt3a, and an inhibitor of MMP3 to the individual. In another embodiment, the present invention provides a method of stabilizing NMJ after nerve injury by inhibiting the WNT and beta-catenin signaling pathway and preserving agrin. |
申请公布号 |
US2014170162(A1) |
申请公布日期 |
2014.06.19 |
申请号 |
US201314133414 |
申请日期 |
2013.12.18 |
申请人 |
The Regents of the University of California |
发明人 |
Gupta Ranjan |
分类号 |
C12N15/113;A61K39/395;A61K31/65;A61K31/165;A61K31/496;A61K31/4709;A61K31/35;A61K31/506;A61K31/513;A61K31/365;A61K38/17;A61K31/519 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating nerve injury in an individual, comprising:
providing a composition comprising one or more of the following: agrin, an inhibitor of the matrix metalloproteinase 3 (MMP3) signaling pathway, an inhibitor of the WNT signaling pathway, and an inhibitor of the beta-catenin signaling pathway; and administering a therapeutically effective dosage of the composition to the individual.
|
地址 |
Oakland CA US |